Express News | Paul Chan Mo-po: The listing of Contemporary Amperex Technology can further enhance the liquidity of Hong Kong Stocks and promote the optimization of market structure.
Express News | The central bank: Increase support for Technology innovation, boost consumption, promote private small and micro enterprises, stabilize foreign trade, and make good use of existing and new policies.
Market Update | All three major stock indices closed higher, the Hang Seng Index rose nearly 1.5%, and the Tech Index rose 1.15%; pharmaceuticals and newly listed consumer stocks collectively strengthened; Contemporary Amperex Technology surged over 16% o
Today, the net inflow for the Hong Kong Stock Connect (southbound) is 6.332 billion HKD. The three major Hong Kong stock indices all rose, with the Hang Seng Index up 1.49%, the Tech Index up 1.15%, and the Hang Seng China Enterprises Index up 1.52%.
Express News | The Hang Seng Index in Hong Kong closed up 1.49%, and the Hang Seng TECH Index rose 1.15%.
Hong Kong stocks in the pharmaceutical sector have surged across the board! Pfizer has made a $6 billion bet on China's anti-cancer drugs.
On Tuesday, the Hong Kong Hang Seng Biotechnology Index soared more than 4%, with 3SBIO rising over 35%. Pfizer and 3SBIO reached an agreement, investing $6 billion in the development of anti-cancer drugs in China, with a prepayment of $0.125 billion. This Trade set a new record in licensing transactions among Chinese pharmaceutical companies.
Hong Kong stock afternoon review | Hang Seng TECH Index rises by 1.32%, Contemporary Amperex Technology IPO rises nearly 17%; the innovation drug Sector is booming, with 3SBIO increasing over 35%.
Contemporary Amperex Technology rose nearly 17% on the first day of its IPO; pharmaceutical stocks surged, with 3SBIO increasing by 35.72%, HANSOH PHARMA by 9.36%, CSPC PHARMA by 6.90%, SIMCERE PHARMA by 5.40%, UNITED LAB by 5.15%, SINO BIOPHARM by 4.68%, GRANDPHARMA by 4.22%, and INNOVENT BIO by 4.15%.
